A research team at the VIB-KU Leuven Center for Microbiology has developed a novel screening method to identify antimicrobial properties of volatile substances. With this assay, they tested the vapour-phase-mediated activity of 175 essential oils (EOs) and 37 EO components. Approximately half of them proved active against the most drug-resistant type of Candida. In a context of fungi showing increasing drug resistance, these findings may be useful in both medical and agricultural applications.
The research project, led by prof. Patrick Van Dijck, is rooted in the growing problem of antifungal drug resistance. Candida cells, for example, are quickly becoming tolerant to fluconazole, the most-used antifungal drug. Next to exploring experimental new techniques, scientists also seek to repurpose existing substances. Plant essential oils (EOs), metabolites obtained by steam distillation or cold citrus peel pressing, may offer interesting opportunities: they are made up of compounds that help protect the plant against microbial or herbivore attacks.
Identifying EOs and their compounds
In the VIB-KU Leuven Center for Microbiology, Adam Feyaerts gathered a collection of 175 different EOs, constituting a collection of over one thousand different small molecules. The aim was to identify biologically active compounds present in these complex mixtures. They therefore developed a new class of assay that allowed to identify new volatile substances with antifungal activities over a distance.
Prof. Patrick Van Dijck (VIB-KU Leuven): “We screened our whole collection of EOs for vapor-phase mediated antifungal activity against two human fungal pathogens, Candida albicans and Candida glabrata. Interestingly, we found that approximately half of the EOs and their compounds had vapour-phase-mediated activity against bothCandida species. Surprisingly, C. glabrata, the most drug-resistant species of the two was on average even more susceptible. In contrast, none of the currently used antifungals showed any vapour-phase-mediated activity.”
Numerous potential applications
This is now the first simple test to look for the vapor-phase-mediated antimicrobial activity of molecules. The same assay could also be used to test other biological activity. And although these findings still have to be confirmed in clinical trials, potential applications are numerous.
Co-author Adam Feyaerts (VIB-KU Leuven): “Our findings are for instance a starting point for the development of molecules that could also be used in vaporizers. After all, volatiles can access otherwise hard to reach areas. Think of possibilities such as maintaining hygiene in hospitals or treat patients with lung infections. There are agricultural options too, such as preventing post-harvest contamination or protecting crops against pests.”
The Latest on: Antifungal drug resistance
via Google News
The Latest on: Antifungal drug resistance
- Drug-resistant fungi are a threat to modern medicine on April 19, 2019 at 7:19 am
When all the other microbes are suppressed, there are more resources available for the resistant microbes to grow and spread rapidly. Receiving antimicrobial drugs, whether antibiotic or antifungal, ... […]
- How a Chicago Woman Fell Victim to Candida Auris, a Drug-Resistant Fungus on April 18, 2019 at 5:43 am
About 90 percent of C. auris strains are resistant to at least one drug, and 30 percent are resistant to two or more of the three major classes of antifungal drugs. However, on Tuesday, the C.D.C. ... […]
- Q&A: What to Know About the Drug-Resistant Fungus, Candida auris on April 18, 2019 at 5:40 am
And in particular, it’s showing to be resistant to multiple classes of antifungal drugs. There’s not good ways to treat it. And it has, I think, an unusual property for fungal infections of causing ... […]
- Deadly, drug resistant fungal infection spreading in hospitals worldwide on April 15, 2019 at 8:03 pm
ATLANTA — A deadly fungal infection is spreading across the globe, and here in the United States, it is getting dangerously close to Georgia, with more than a dozen cases reported in Florida. Known as ... […]
- Antifungal Drugs Market Size Driving Factors, Industry Growth, Key Vendors and Forecasts to 2024 on April 15, 2019 at 10:18 am
However, growing portfolio of antifungal generic drugs, patent expiration of innovator drugs, increasing prevalence of fungal resistance, and counterfeit drugs are expected to hinder the market ... […]
- As Drug Resistance Grows, Amplyx Tests New Antifungal Drug on April 15, 2019 at 9:52 am
While fungal infections may seem like an annoyance rather than a serious health problem, sick people in hospitals and long-term care facilities are contracting potentially deadly infections that ... […]
- The Threat of Drug-Resistant Infections on April 14, 2019 at 10:00 am
Thank you for “Fungus Immune to Drugs Quietly Sweeps the Globe” (“Deadly Germs, Lost Cures” series, front page, April 7), on the threats of infections that have grown resistant to the medicines ... […]
- Drug-resistant fungus is sprouting worldwide, and it has health researchers worried on April 14, 2019 at 3:00 am
Another is that we just don’t have that many drugs. There are just three major families of antifungal medication, and according to a review article published in Science in 2018, some samples of ... […]
- How Do Hospitals Stop the Spread of Drug-Resistant Superbugs Like C. Auris? on April 12, 2019 at 3:47 pm
On Saturday, the New York Times published a fascinating and anxiety-inducing article about the rise of an antifungal-resistant ... to stop the spread of these drug-resistant superbugs? […]
- Everything You Need to Know About Drug-Resistant Fungus on April 10, 2019 at 3:59 pm
A deadly fungus that’s resistant to commonly used antifungal medications is spreading in healthcare ... “With this species, we are starting to see that it is not only resistant to one drug,” said ... […]
via Bing News